• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估细胞宿主反应测试在急诊科疑似 COVID-19 患者中的风险分层作用。

Assessment of a cellular host response test to risk-stratify suspected COVID-19 patients in the Emergency Department setting.

机构信息

Louisiana State University Health Sciences Center, Baton Rouge, Louisiana, United States of America.

Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States of America.

出版信息

PLoS One. 2022 Mar 16;17(3):e0264220. doi: 10.1371/journal.pone.0264220. eCollection 2022.

DOI:10.1371/journal.pone.0264220
PMID:35294441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8926179/
Abstract

OBJECTIVE

Assess the IntelliSep Index (ISI) for risk stratification of patients presenting to the Emergency Department (ED) with respiratory symptoms suspected of COVID-19 during the pandemic.

METHODS

An observational single-center study of prospective cohort of patients presenting to the ED during the early COVID-19 pandemic with respiratory symptoms and a CBC drawn within 4.5 hours of initial vital signs. A sample of this blood was aliquoted for performance of the ISI, and patients were followed for clinical outcomes. The study required no patient-centered activity beyond standard of care and treating clinicians were unaware of study enrollment and ISI test results.

MAIN FINDINGS

282 patients were included. The ISI ranges 0.1 to 10.0, with three interpretation bands indicating risk of adverse outcome: low (green), 0.1-4.9; intermediate (yellow), 5.0-6.2; and high (red), 6.3-10.0. Of 193 (68.4%) tested for SARS-CoV-2, 96 (49.7%) were positive. The ISI resulted in 182 (64.5%) green, 54 (18.1%) yellow, and 46 (15.6%) red band patients. Green band patients had a 1.1% (n = 2) 3-day mortality, while yellow and red band had 3.7% (n = 2, p > .05) and 10.9% (n = 5, p < .05) 3-day mortalities, respectively. Fewer green band patients required admission (96 [52.7%]) vs yellow (44 [81.5%]) and red (43 [93.5%]). Green band patients had more hospital free days (median 23 (Q1-Q3 20-25) than yellow (median 22 [Q1-Q3 0-23], p < 0.05) and red (median 21 [Q1-Q3 0-24], p < 0.01). SOFA increased with interpretation band: green (2, [Q1-Q3 0-4]) vs yellow (4, [Q1-Q3 2-5], p < 0.001) and red (5, [Q1-Q3 3-6]) p < 0.001).

CONCLUSIONS

The ISI rapidly risk-stratifies patients presenting to the ED during the early COVID-19 pandemic with signs or suspicion of respiratory infection.

摘要

目的

评估 IntelliSep Index(ISI)在大流行期间因 COVID-19 呼吸道症状而就诊于急诊科的患者的风险分层。

方法

对大流行早期因 COVID-19 呼吸道症状和在初始生命体征后 4.5 小时内抽取的全血细胞计数(CBC)而就诊于急诊科的患者进行前瞻性队列观察性单中心研究。对该血液样本进行了 ISI 检测,并对患者进行了临床结局随访。该研究除了标准护理外不需要患者参与,并且治疗医生不知道研究入组和 ISI 检测结果。

主要发现

共纳入 282 例患者。ISI 范围为 0.1 至 10.0,有三个解释带表示不良结局的风险:低(绿色),0.1-4.9;中(黄色),5.0-6.2;高(红色),6.3-10.0。在 193 例接受 SARS-CoV-2 检测的患者中,96 例(49.7%)呈阳性。ISI 结果为 182 例(64.5%)为绿色带,54 例(18.1%)为黄色带,46 例(15.6%)为红色带。绿色带患者的 3 天死亡率为 1.1%(n=2),而黄色带和红色带的 3 天死亡率分别为 3.7%(n=2,p>.05)和 10.9%(n=5,p<.05)。需要住院治疗的绿色带患者(96 [52.7%])少于黄色带(44 [81.5%])和红色带(43 [93.5%])。绿色带患者的住院天数(中位数 23 [Q1-Q3 20-25])多于黄色带(中位数 22 [Q1-Q3 0-23],p<.05)和红色带(中位数 21 [Q1-Q3 0-24],p<.01)。SOFA 随解释带增加:绿色(2,[Q1-Q3 0-4])与黄色(4,[Q1-Q3 2-5],p<.001)和红色(5,[Q1-Q3 3-6],p<.001)。

结论

在大流行早期因 COVID-19 呼吸道症状就诊于急诊科的患者中,ISI 可快速对患者进行风险分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/d088ac1e0835/pone.0264220.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/515a8b6e9ad7/pone.0264220.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/815d817c488d/pone.0264220.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/1e13fe16608a/pone.0264220.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/8a3967ee3102/pone.0264220.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/d088ac1e0835/pone.0264220.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/515a8b6e9ad7/pone.0264220.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/815d817c488d/pone.0264220.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/1e13fe16608a/pone.0264220.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/8a3967ee3102/pone.0264220.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7946/8926179/d088ac1e0835/pone.0264220.g005.jpg

相似文献

1
Assessment of a cellular host response test to risk-stratify suspected COVID-19 patients in the Emergency Department setting.评估细胞宿主反应测试在急诊科疑似 COVID-19 患者中的风险分层作用。
PLoS One. 2022 Mar 16;17(3):e0264220. doi: 10.1371/journal.pone.0264220. eCollection 2022.
2
Validation of a Novel, Rapid Sepsis Diagnostic for Emergency Department Use.一种用于急诊科的新型快速脓毒症诊断方法的验证
Crit Care Explor. 2024 Feb 7;6(2):e1026. doi: 10.1097/CCE.0000000000001026. eCollection 2024 Feb.
3
Development and validation of a cellular host response test as an early diagnostic for sepsis.开发和验证细胞宿主反应测试作为败血症的早期诊断方法。
PLoS One. 2021 Apr 15;16(4):e0246980. doi: 10.1371/journal.pone.0246980. eCollection 2021.
4
Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial.疑似脓毒症相关性低血压患者的限制性液体复苏(REFRESH):一项先导随机对照试验。
Intensive Care Med. 2018 Dec;44(12):2070-2078. doi: 10.1007/s00134-018-5433-0. Epub 2018 Oct 31.
5
The Impact of COVID-19 Lockdown on the Incidence of Type 1 DM and the Glycemic Control of Diabetic Children: Findings from a Teaching Hospital, Saudi Arabia.COVID-19 封锁对 1 型糖尿病发病率和糖尿病儿童血糖控制的影响:来自沙特阿拉伯一所教学医院的发现。
Rev Diabet Stud. 2022 Sep 28;18(3):152-156. doi: 10.1900/RDS.2022.18.152.
6
Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4).澳大利亚“第二波”疫情中急诊科疑似 COVID-19 患者的流行病学和临床特征(COVED-4)。
Emerg Med Australas. 2021 Apr;33(2):331-342. doi: 10.1111/1742-6723.13706. Epub 2021 Jan 6.
7
Epidemiology and clinical features of emergency department patients with suspected COVID-19: Initial results from the COVID-19 Emergency Department Quality Improvement Project (COVED-1).急诊科疑似 COVID-19 患者的流行病学和临床特征:COVID-19 急诊科质量改进项目(COVED-1)的初步结果。
Emerg Med Australas. 2020 Aug;32(4):638-645. doi: 10.1111/1742-6723.13540. Epub 2020 May 18.
8
Characterisation of 22445 patients attending UK emergency departments with suspected COVID-19 infection: Observational cohort study.22445 名英国急诊科疑似 COVID-19 感染患者的特征:观察性队列研究。
PLoS One. 2020 Nov 25;15(11):e0240206. doi: 10.1371/journal.pone.0240206. eCollection 2020.
9
Which parameters support disposition decision in suspected COVID-19 cases in the emergency department (ED): a German clinical cohort study.哪些参数支持急诊科疑似 COVID-19 病例的处置决策:一项德国临床队列研究。
BMJ Open. 2021 Mar 31;11(3):e044853. doi: 10.1136/bmjopen-2020-044853.
10
The Association Between Pressure Ulcer/Injury Development and Short-term Mortality in Critically Ill Patients: A Retrospective Cohort Study.危重患者压力性溃疡/损伤发展与短期死亡率之间的关联:一项回顾性队列研究。
Wound Manag Prev. 2020 Feb;66(2):14-21. doi: 10.25270/wmp.2020.2.1421.

引用本文的文献

1
Validation of a Novel, Rapid Sepsis Diagnostic for Emergency Department Use.一种用于急诊科的新型快速脓毒症诊断方法的验证
Crit Care Explor. 2024 Feb 7;6(2):e1026. doi: 10.1097/CCE.0000000000001026. eCollection 2024 Feb.
2
Variability in Provider Assessment of Sepsis and Potential of Host Response Technology to Address this Dilemma-Results of an Online Delphi Study.脓毒症医疗服务提供者评估的变异性以及宿主反应技术解决这一困境的潜力——一项在线德尔菲研究的结果
J Pers Med. 2023 Dec 5;13(12):1685. doi: 10.3390/jpm13121685.
3
Biophysical Changes of Leukocyte Activation (and NETosis) in the Cellular Host Response to Sepsis.

本文引用的文献

1
Assessment of a Cellular Host Response Test as a Sepsis Diagnostic for Those With Suspected Infection in the Emergency Department.评估细胞宿主反应检测作为急诊科疑似感染患者脓毒症诊断方法的效果。
Crit Care Explor. 2021 Jun 15;3(6):e0460. doi: 10.1097/CCE.0000000000000460. eCollection 2021 Jun.
2
Development and validation of a cellular host response test as an early diagnostic for sepsis.开发和验证细胞宿主反应测试作为败血症的早期诊断方法。
PLoS One. 2021 Apr 15;16(4):e0246980. doi: 10.1371/journal.pone.0246980. eCollection 2021.
3
Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies.
细胞宿主对脓毒症反应中白细胞激活(及中性粒细胞胞外陷阱形成)的生物物理变化
Diagnostics (Basel). 2023 Apr 16;13(8):1435. doi: 10.3390/diagnostics13081435.
COVID-19 中的宿主-病原体相互作用:发病机制、潜在治疗方法和疫苗接种策略。
Immunobiology. 2020 Nov;225(6):152008. doi: 10.1016/j.imbio.2020.152008. Epub 2020 Aug 19.
4
COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department.基于 sTREM-1 和 IL-6 的急诊科 COVID-19 风险分层算法。
J Allergy Clin Immunol. 2021 Jan;147(1):99-106.e4. doi: 10.1016/j.jaci.2020.10.001. Epub 2020 Oct 9.
5
Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019.急性生理学与慢性健康状况评估系统 II 评分对新型冠状病毒肺炎患者住院病死率的预测价值。
Crit Care Med. 2020 Aug;48(8):e657-e665. doi: 10.1097/CCM.0000000000004411.
6
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.2019 年冠状病毒病病例监测-美国,2020 年 1 月 22 日-5 月 30 日。
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765. doi: 10.15585/mmwr.mm6924e2.
7
Pulse Oximetry for Monitoring Patients with COVID-19 at Home. Potential Pitfalls and Practical Guidance.脉氧仪在家中监测 COVID-19 患者:潜在陷阱与实用指南。
Ann Am Thorac Soc. 2020 Sep;17(9):1040-1046. doi: 10.1513/AnnalsATS.202005-418FR.
8
Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19.C反应蛋白水平升高可能是预测新冠病毒疾病严重程度风险的早期标志物。
J Med Virol. 2020 Nov;92(11):2409-2411. doi: 10.1002/jmv.26097. Epub 2020 Jun 9.
9
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素:前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
10
The hallmarks of COVID-19 disease.新型冠状病毒疾病的特征。
PLoS Pathog. 2020 May 22;16(5):e1008536. doi: 10.1371/journal.ppat.1008536. eCollection 2020 May.